Health

Over the past few years, roughly a fifth to a quarter of all corporate investors whose deals we track appear to be newcomers.

M12 backed three deals in recent days, including a $50m series D round for Split.io that also featured fellow corporates Atlassian and ServiceNow.

ThunderSoft-backed Shukun Technology has revealed fresh funding as it looks to develop its AI technology.

The Amgen-backed neurodegenerative disease treatment specialist is set to fund new medical studies.

Immunitas Therapeutics has reached $97m of total funding after announcing the close of its series B round featuring more than half a dozen corporates.

Backed by one of the biggest names in pharma, the studio looks to shake up consumer healthcare markets

HiberCell has acquired genomics analytic services provider Genuity Science, which had previously been bought by WuXi AppTec before being spun off last year.

Bluesail Medical-backed mechanical heart pump developer Tongxin has collected at least $30.8m of series D funding.

National Grid Partners contributed to data protection software provider Baffle's series B round while Axa and Zendesk exited sales enablement platform developer Seismic.

Dexcel Pharma joins second funding round for BrainQ’s artificial intelligence (AI)-based technology.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.